What is Promescent?
Promescent is dedicated to enhancing sexual wellness through a diverse range of products, including delay sprays, lubricants, condoms, dietary supplements, and intimacy devices. With a recommendation base of over 4,000 doctors globally, the company focuses on improving sexual experiences for its clientele. Promescent emphasizes privacy through discreet packaging and offers free shipping within the United States for orders exceeding $20, positioning itself as a discreet and trusted provider in the sexual wellness market.
How much funding has Promescent raised?
Promescent has raised a total of $1.8M across 2 funding rounds:
Private Equity
$561K
Private Equity
$1.2M
Private Equity (2012): $561K, investors not publicly disclosed
Private Equity (2013): $1.2M, investors not publicly disclosed
What's next for Promescent?
The substantial enterprise-level funding secured by Promescent indicates a strategic push towards scaling operations and expanding its market reach. This capital infusion is likely to fuel further product development, enhance marketing initiatives, and potentially explore new distribution channels. The company's focus on doctor recommendations and discreet consumer experience suggests a strategy aimed at building long-term trust and brand loyalty within the sexual wellness sector. Future growth may involve deeper penetration into existing markets and the introduction of innovative solutions to meet evolving consumer needs.
See full Promescent company page
